Drug Shortage Report for ACT PAROXETINE
Report ID | 102941 |
Drug Identification Number | 02262754 |
Brand name | ACT PAROXETINE |
Common or Proper name | ACT-PAROXETINE 20MG FC TAB |
Company Name | ACTAVIS PHARMA COMPANY |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | PAROXETINE |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 500 |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2020-01-09 |
Estimated end date | |
Actual end date | 2020-01-23 |
Shortage status | Resolved |
Updated date | 2020-01-24 |
Company comments | Item is disc. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-01-09 | English | Compare |
v2 | 2020-01-09 | French | Compare |
v3 | 2020-01-10 | English | Compare |
v4 | 2020-01-24 | English | Compare |
v5 | 2020-01-24 | French | Compare |
Showing 1 to 5 of 5